Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 28397 | 169 | 20.4 | 32% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ALKOXYCOUMARIN DEALKYLASE | Author keyword | 3 | 100% | 2% | 3 |
| 2 | PHENAZEPAM | Author keyword | 2 | 27% | 4% | 7 |
| 3 | GIDAZEPAM | Author keyword | 1 | 50% | 1% | 2 |
| 4 | DRUG PHARMACOKINET | Address | 1 | 50% | 1% | 1 |
| 5 | LEVANA | Author keyword | 1 | 50% | 1% | 1 |
| 6 | SLEEP INDUCER | Author keyword | 1 | 50% | 1% | 1 |
| 7 | FLUMECINOL | Author keyword | 0 | 33% | 1% | 1 |
| 8 | DAILY FLUCTUATION | Author keyword | 0 | 15% | 1% | 2 |
| 9 | A V BOGATSKII PHYSICOCHEM | Address | 0 | 25% | 1% | 1 |
| 10 | HEPATIC AVAILABILITY | Author keyword | 0 | 25% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ALKOXYCOUMARIN DEALKYLASE | 3 | 100% | 2% | 3 | Search ALKOXYCOUMARIN+DEALKYLASE | Search ALKOXYCOUMARIN+DEALKYLASE |
| 2 | PHENAZEPAM | 2 | 27% | 4% | 7 | Search PHENAZEPAM | Search PHENAZEPAM |
| 3 | GIDAZEPAM | 1 | 50% | 1% | 2 | Search GIDAZEPAM | Search GIDAZEPAM |
| 4 | LEVANA | 1 | 50% | 1% | 1 | Search LEVANA | Search LEVANA |
| 5 | SLEEP INDUCER | 1 | 50% | 1% | 1 | Search SLEEP+INDUCER | Search SLEEP+INDUCER |
| 6 | FLUMECINOL | 0 | 33% | 1% | 1 | Search FLUMECINOL | Search FLUMECINOL |
| 7 | DAILY FLUCTUATION | 0 | 15% | 1% | 2 | Search DAILY+FLUCTUATION | Search DAILY+FLUCTUATION |
| 8 | HEPATIC AVAILABILITY | 0 | 25% | 1% | 1 | Search HEPATIC+AVAILABILITY | Search HEPATIC+AVAILABILITY |
| 9 | PURKINJE NEURONE | 0 | 17% | 1% | 1 | Search PURKINJE+NEURONE | Search PURKINJE+NEURONE |
| 10 | MULTIPLE INDICATOR DILUTION METHOD | 0 | 11% | 1% | 1 | Search MULTIPLE+INDICATOR+DILUTION+METHOD | Search MULTIPLE+INDICATOR+DILUTION+METHOD |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | 450191 S | 1 | 50% | 1% | 1 |
| 2 | 7 ALKOXYCOUMARIN O DEALKYLASE | 1 | 29% | 1% | 2 |
| 3 | PHENAZEPAM | 0 | 33% | 1% | 1 |
| 4 | SLEEP INDUCER | 0 | 100% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Phenazepam: The drug that came in from the cold | 2012 | 7 | 7 | 71% |
| STRUCTURE OF PEPTIDAMIDOBENZOPHENONE AND PEPTIDAMIDOBENZHYDROL METABOLITES | 1989 | 0 | 3 | 100% |
| STRATEGY OF THE METABOLITE-BASED QUEST FOR PHYSIOLOGICALLY ACTIVE COMPOUNDS | 1985 | 0 | 1 | 100% |
| ACTIVE-DRUG METABOLITES - AN OVERVIEW OF THEIR RELEVANCE IN CLINICAL PHARMACOKINETICS | 1985 | 32 | 34 | 15% |
| TOXIC EFFECTS OF CHEMICALS - DIFFICULTIES IN EXTRAPOLATING DATA FROM ANIMALS TO MAN | 1985 | 21 | 78 | 8% |
| PHARMACOLOGY OF A NEW SLEEP INDUCER, 1H-1, 2, 4-TRIAZOLYL BENZOPHENONE DERIVATIVE, 450191-S .2. SLEEP-INDUCING ACTIVITY AND EFFECT ON THE MOTOR SYSTEM | 1984 | 6 | 36 | 14% |
| IMPORTANCE OF ESTABLISHING THE PRESENCE OF DRUG ACTIVE METABOLITES | 1983 | 1 | 9 | 33% |
| BIBLIOGRAPHY OF RECENT LITERATURE IN SLEEP RESEARCH | 1987 | 0 | 130 | 5% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DRUG PHARMACOKINET | 1 | 50% | 0.6% | 1 |
| 2 | A V BOGATSKII PHYSICOCHEM | 0 | 25% | 0.6% | 1 |
| 3 | PHARMACOL COMM | 0 | 25% | 0.6% | 1 |
| 4 | REG CRIME | 0 | 25% | 0.6% | 1 |
| 5 | CLIN TOXICOL SERV | 0 | 13% | 0.6% | 1 |
| 6 | PROGRAMME SUBST ABUSE DEATHS | 0 | 10% | 0.6% | 1 |
| 7 | CANC 441 KOMATSUSHIMA AOBA KU | 0 | 100% | 0.6% | 1 |
| 8 | CHEM BIOL ACT SUBSTANCES | 0 | 100% | 0.6% | 1 |
| 9 | SYNTH MED PREPARAT PHIL 5 | 0 | 100% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000189494 | BENZODIAZEPINOOXAZOLE//DAYA DRUG DISCOVERIES INC//PHARM NAKA KU |
| 2 | 0.0000140499 | I 125 IOMAZENIL//ACQUISITION OF OPERANT BEHAVIOR//ACTIVE SHUTTLEBOX AVOIDANCE |
| 3 | 0.0000138920 | TRIMELAMOL//HEXAMETHYLMELAMINE//DEHYDROEMETINE |
| 4 | 0.0000120616 | TELE STEREO EEG//ELECTROPHARMACOGRAM//CATEEM |
| 5 | 0.0000103501 | 7 AMINOFLUNITRAZEPAM//BROMAZEPAM//FLUNITRAZEPAM |
| 6 | 0.0000087017 | K M AND V MAX//PERFUSED MOUSE LIVER//N DESMETHYLDIAZEPAM |
| 7 | 0.0000084964 | PSYCHOEMOTIONAL DISORDERS//COLLAGEN METABOLITES//BLOOD TYROSINE |
| 8 | 0.0000079363 | BRETAZENIL//ABECARNIL//FLUMAZENIL |
| 9 | 0.0000074395 | ESR AND ENDOR STUDIES//RAMAN MONITORING//MULTIFUNCTIONAL MOLECULE |
| 10 | 0.0000068472 | OZONE UV IRRADIATION//FERROUS ION AUTOXIDATION//DODECYLBENZENESULFONATE |